Literature DB >> 19759475

Clinico-pathological study of atypical pathogens in community-acquired pneumonia: a prospective study.

Maysaa El Sayed Zaki1, Tarek Goda.   

Abstract

BACKGROUND: Atypical respiratory pathogens such as Mycoplasma pneumoniae, Legionella species, and Chlamydia pneumoniae are isolated with increasing frequency from community-acquired pneumonia (CAP). This study highlights the importance of organisms responsible for CAP.
METHODOLOGY: One hundred consecutive patients with clinically and radiographically diagnosed CAP were evaluated from October 2005 to October 2006. Sputum, bronchoalveolar lavage, and blood samples were collected for microbiological culture. Determination was performed for specific immunoglobulin M (IgM) for Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophila, Coxiella burnettii, adenovirus, and influenza virus.
RESULTS: The most common isolated bacteria was Streptococcus pneumoniae (22%) followed by Haemophilus influenzae (18%). Mycoplasma pneumoniae was isolated from 5% and Legionella pneumophila was isolated from 5% of patients. The most common positive serological reaction was for Chlamydia pneumoniae (30%) and Adenovirus (30%). In the study of accuracy of determination of specific IgM for Mycoplasma pneumoniae and Legionella pneumophila compared to culture, the sensitivity was 60% and 80% respectively, specificity was 93.7 %, and 98.9 % respectively, and accuracy was 92 % and 97 % respectively.
CONCLUSION: This study highlights the prominence of mixed bacterial/viral infections in lower respiratory tract infection diagnosis. Our data showed that at least 30% of our patients had concurrent infections. This observation raises two important questions: 1) whether sequential or concurrent viral and bacterial infections have a synergistic impact on the evolution of disease in children; and 2) should diagnostic batteries for any patient with CAP include methods for detecting both the typical and atypical bacterial or viral pathogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759475     DOI: 10.3855/jidc.36

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  6 in total

1.  Viral etiologies of lower respiratory tract infections among Egyptian children under five years of age.

Authors:  Caroline F Shafik; Emad W Mohareb; Aymen S Yassin; Madgy A Amin; Amani El Kholy; Hanaa El-Karaksy; Fouad G Youssef
Journal:  BMC Infect Dis       Date:  2012-12-13       Impact factor: 3.090

Review 2.  [Epidemiology of Q fever in Spain (2018)].

Authors:  J L Pérez-Arellano; C Carranza Rodríguez; C Gutierrez; M Bolaños Rivero
Journal:  Rev Esp Quimioter       Date:  2018-07-19       Impact factor: 1.553

3.  Molecular detection of respiratory pathogens among children aged younger than 5 years hospitalized with febrile acute respiratory infections: A prospective hospital-based observational study in Niamey, Niger.

Authors:  Adamou Lagare; Sani Ousmane; Ibrahim Dan Dano; Bassira Issaka; Idi Issa; Halima Boubacar Mainassara; Jean Testa; Stefano Tempia; Saidou Mamadou
Journal:  Health Sci Rep       Date:  2019-10-11

4.  Bacterial profile, antibiotic sensitivity and resistance of lower respiratory tract infections in upper egypt.

Authors:  Gamal Agmy; Sherif Mohamed; Yaser Gad; Esam Farghally; Hamdy Mohammedin; Hebba Rashed
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

5.  Molecular identification of adenoviruses associated with respiratory infection in Egypt from 2003 to 2010.

Authors:  Pola N Demian; Katherine C Horton; Adriana Kajon; Rania Siam; Amel Mohamed Nageib Hasanin; Amany Elgohary Sheta; Claire Cornelius; Anne M Gaynor
Journal:  BMC Infect Dis       Date:  2014-01-30       Impact factor: 3.090

6.  Viral and bacterial etiology of severe acute respiratory illness among children < 5 years of age without influenza in Niger.

Authors:  Adamou Lagare; Halima Boubacar Maïnassara; Bassira Issaka; Ali Sidiki; Stefano Tempia
Journal:  BMC Infect Dis       Date:  2015-11-14       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.